In this episode of the Heartbeat Podcast, we explore the groundbreaking ABYSS trial, which investigates the controversial topic of beta-blocker therapy in patients with a history of myocardial infarction. Should beta-blockers be continued indefinitely, or is it safe to discontinue them after stabilization? Join us as we delve into the study's methods, findings, and implications for clinical practice. We discuss key outcomes, such as cardiovascular events and quality of life, to provide a comprehensive understanding of this pivotal research.
Listen now to discover how this study could reshape post-myocardial infarction care and spark new discussions in cardiology.
Podden och tillhörande omslagsbild på den här sidan tillhör
Mohammed Al-Qadami. Innehållet i podden är skapat av Mohammed Al-Qadami och inte av,
eller tillsammans med, Poddtoppen.
